47 matches for your search in the start-up spotlight
rss
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Our G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only if there is a highly specific match between the guide RNA and an intracellular RNA sequence, ...
Our mission is to improve the life quality of patients depending on painful injectable drugs by offering them the OctoPatch® − a small painless patch that can be easily self-applied to the inner side of the cheek. Our patented OctoPatch® technology is inspired by an octopus sucker. It applies ...
Sedivention develops a break-through, widely applicable, device for interventional obesity therapy. Hunger is transmitted from the stomach to the brain by the gastric trunks of the vagal nerve. Sedivention is developing a cryo-balloon freezing the gastric branches of the vagal nerve from inside ...
Founded in 2023, OSORA is a digital-twin powered predictive bone healing simulation which estimates the patient-specific healing process in the bone. Our software platform enables the prediction of the load-bearing capacity of the bone during the treatment process. First applications of the ...
4Tissue is a biotech company at the forefront of regenerative medicine, utilizing advanced bio-interactive hydrogels to transition from cells to tissue engineering. Founded through a collaboration between Prof. Phillip Blondeel, a global leader in plastic and reconstructive surgery, and Prof. Dr. ...
Impli is a pioneering biotechnology company dedicated to revolutionizing accessibility and efficacy in the world of in vitro fertilization (IVF). Our breakthrough innovation, a biosensing platform, a novel combination of electronics and subdermal biosensors, allows for the continuous monitoring ...
We are a spin-off company out of the Angiology Division of the Lausanne University Hospital (CHUV) and of the Laboratory of Lymphatic and Cancer Bioengineering of the Swiss Federal Institute of Technology in Lausanne (EPFL). Lymphatica Medtech was founded in 2017 by Dr. Triacca and Dr. Pisano, ...
Developing a all-in-one surgical system that makes minimally-invasive procedures more efficient.
